Related Experiment Video

Updated: Aug 26, 2026

Examining BCL-2 Family Function with Large Unilamellar Vesicles
08:35

Examining BCL-2 Family Function with Large Unilamellar Vesicles

Published on: October 5, 2012

Minocycline up-regulates Bcl-2 and protects against cell death in mitochondria

Jinzhao Wang1, Qingqing Wei, Cong-Yi Wang

  • 1Department of Cell Biology and Anatomy, Medical College of Georgia, 1459 Laney Walker Boulevard, Augusta, GA 30912, USA.

The Journal of Biological Chemistry
|March 9, 2004
PubMed

Insights

Minocycline demonstrates neuroprotective effects and also protects kidney cells from injury. Its protective mechanism involves upregulating Bcl-2, an antiapoptotic protein, particularly at the mitochondria.

Area of Science:

  • Cell Biology
  • Pharmacology
  • Nephrology

Background:

  • Minocycline is known for its neuroprotective properties.
  • The protective mechanisms of minocycline are not fully understood.
  • Its effects on nonneuronal cells and tissues are largely unknown.

Purpose of the Study:

  • To investigate the protective effects of minocycline on kidney epithelial cells in vitro and in vivo.
  • To elucidate the molecular mechanisms underlying minocycline's cytoprotective actions.
  • To determine the role of Bcl-2 in minocycline-mediated protection.

Main Methods:

  • In vitro studies using kidney epithelial cells exposed to various apoptotic stimuli (hypoxia, azide, cisplatin, staurosporine).
  • In vivo assessment of kidney injury following ischemic events.
  • Mitochondrial function analysis, including Bax, Bak, and Bid interactions.
  • Manipulation of Bcl-2 expression using antisense oligonucleotides.

Main Results:

  • Minocycline protected kidney epithelial cells from apoptosis induced by multiple stressors.
  • Protection was observed in vivo against kidney ischemic injury.
  • Minocycline induced Bcl-2 expression, leading to its accumulation in mitochondria.
  • Bcl-2 interacted with pro-apoptotic proteins (Bax, Bak, Bid) at the mitochondria.
  • Downregulation of Bcl-2 abolished minocycline's protective effects.

Conclusions:

  • Minocycline exhibits protective effects on both neuronal and nonneuronal cells, including kidney tissues.
  • A key mechanism of minocycline's protection involves the induction of the antiapoptotic protein Bcl-2.
  • Bcl-2 plays a critical role in mediating minocycline's cytoprotective effects at the mitochondrial level.

More Related Videos

Experimental Approaches to Study Mitochondrial Localization and Function of a Nuclear Cell Cycle Kinase, Cdk113:15

Experimental Approaches to Study Mitochondrial Localization and Function of a Nuclear Cell Cycle Kinase, Cdk1

Published on: February 25, 2016

Detection of Mitochondria Membrane Potential to Study CLIC4 Knockdown-induced HN4 Cell Apoptosis In Vitro13:20

Detection of Mitochondria Membrane Potential to Study CLIC4 Knockdown-induced HN4 Cell Apoptosis In Vitro

Published on: July 17, 2018

Related Concept Videos

The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
Electron Transport Chain: Complex I and II01:46

Electron Transport Chain: Complex I and II

The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
Cellular Injury V: Apoptosis and Autophagy01:22

Cellular Injury V: Apoptosis and Autophagy

Cells respond to damage and stress through highly coordinated processes that decide whether they survive or undergo controlled self-destruction. Two major pathways involved in this regulation are apoptosis, a type of programmed cell death, and autophagy, a survival mechanism that helps cells adapt to adverse conditions.ApoptosisApoptosis removes aged or injured cells to maintain tissue balance. During this process, the cell shrinks, chromatin condenses and fragments, and membrane-bound...
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
Drugs that Stabilize Microtubules01:15

Drugs that Stabilize Microtubules

Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...